Thursday , August 17 2017
Home / 2015 / January

Monthly Archives: January 2015

Biogen Partners to Develop Gene Therapies for Hemophilia

Biogen Idec is teaming up with Fondazione Telethon and Ospedale San Raffaele to develop gene therapies for hemophilia A and B. The worldwide collaboration will combine San Raffaele-Telethon Institute for Gene Therapy’s (TIGET) extensive expertise in creating new gene therapy strategies and developing them from bench to bedside with Biogen’s …

Read More »

Quest Diagnostics and CDC Partner to Improve Hepatitis Diagnosis and Treatment

Quest Diagnostics is collaborating with the Centers for Disease Control and Prevention (CDC) to identify trends in screening, diagnosis and treatment of four strains of viral hepatitis in the US. Quest Diagnostics will provide CDC researchers with analytics and access to its national database of de-identified clinical testing hepatitis data. …

Read More »

PARI’s Electronic Nebulizer Receives FDA Approval for Cystic Fibrosis Patients

The US Food and Drug Administration (FDA) has approved the first electronic nebulizer to deliver cystic fibrosis patients their therapy. The agency approved PARI’s eRapid nebulizer system to deliver Genentech’s Pulmozyme (dornase alfa [recombinant human DNase] for treatment of cystic fibrosis (CF). According to PARI, eRapid cuts the average treatment …

Read More »

Amgen Submits Applications for Approval of its Multiple Myeloma Drug Kyprolis in the US and Europe

Amgen and its subsidiary Onyx Pharmaceuticals, Inc. recently announced that it has submitted applications to both US and EU health regulators for approval of Kyprolis (carfilzomib) for treatment of multiple myeloma. The companies said that they have submitted a supplemental New Drug Application (sNDA) to the US Food and Drug …

Read More »

mHealth Tools Significantly Improve Adherence Among HIV Patients

New mobile health (mHealth) tools have demonstrated effectiveness in aiding HIV patients better manage their disease through improved medication adherence. After analyzing data regarding the effectiveness in mobile pharmacy apps in helping HIV patients, mscripts and Avella Specialty Pharmacy found that HIV patients using a mobile app which provides refill …

Read More »

Scientists Use Modified RNA for Telomere Extension

Scientists discovered a new procedure that can quickly and efficiently increase the length of human telomeres, which could help in a range of diseases, including Duchenne muscular dystrophy (DMD) to diabetes. Researchers from the Stanford University School of Medicine used modified messenger RNA to extend telomeres, the protective caps on …

Read More »

Biosimilars: Close to the Real Thing

The issue of “biosimilar” medications has been under debate for years. Now, the U.S. Food and Drug Administration (FDA) is on the cusp of approving the first biosimilar. In case you don’t know, biosimilars are less expensive versions of already approved biological medications used for cancer, autoimmune, and other diseases. …

Read More »

Insys’ Ovarian Cancer Treatment Receives Orphan Drug Designation from the FDA

The US Food and Drug Administration (FDA) granted Orphan Drug designation for Insys Therapeutics’ ovarian cancer candidate. The agency granted the designation to Insys’ Liposomal Encapsulated Paclitaxel (LEP) candidate for the treatment of ovarian cancer. The FDA’s Office of Orphan Products Development grants novel drugs or biologics that treat rare …

Read More »